2192 ⎘
Genetically modified animals; Animal model comprising regulated expression system Animal model comprising tissue-specific expression system, e.g. tissue specific expression of transgene, of Cre recombinase
METHOD AND ANIMAL MODEL FOR INDUCING BCC TUMORS
#2ANIMAL MODEL OF TDP-43 PROTEINOPATHY
#3SCREENING METHODS FOR TARGETS FOR CANCER THERAPY
#4A RODENT MODEL OF FIBRODYSPLASIA OSSIFICANS PROGRESSIVA
#5METHODS FOR PRODUCING ANTIGEN-BINDING PROTEINS AGAINST FOREIGN ANTIGENS
#6HUMAN LIVER CHIMERIC NON-HUMAN ANIMAL WITH DEFICIENT P450 OXIDOREDUCTASE AND METHODS OF USING SAME
#7MEASUREMENT OF SOMATIC L1 RETROTRANSPOSITION ACTIVITY
#8THERAPIES WITH LANTHIONINE C-LIKE PROTEIN 2 LIGANDS AND CELLS PREPARED THEREWITH
#9TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
#10ANIMAL MODELS OF RECCURRENT HEPATOCELLULAR CARCINOMA AND USES THEREOF
#11TRANSGENIC MICE WITH HUMANIZED MHC I AND IMMUNOGLOBLUIN HEAVY CHAIN GENES
#12TRANSGENIC MICE WITH HUMANIZED MHC I AND IMMUNOGLOBLUIN HEAVY CHAIN GENES
#13FULL-LENGTH HUMAN ACE2 MOUSE MODEL SUSCEPTIBLE TO EMERGING CORONAVIRUSES
#14NEURODEGENERATIVE AND AMYOTROPHIC MODEL ANIMAL
#15ANTIBODY PRODUCTION
#16HUMAN IMMUNOGLOBULIN HEAVY CHAIN LONG CDR3 TRANSGENE CONSTRUCTS AND USES THEREOF
#17CYTOPLASMIC INCOMPATIBILITY FACTORS AND METHODS FOR CONTROLLING ANTHROPODS
#18ANTIBODY PRODUCING NON-HUMAN ANIMALS
#19ANTIBODY PRODUCING NON-HUMAN ANIMALS
#20GENETICALLY MODIFIED RAT MODELS FOR SEVERE COMBINED IMMUNODEFICIENCY (SCID)
#21Recombinant constructs and transgenic fluorescent ornamental fish therefrom
#22REGULATORS OF B CELL-MEDIATED IMMUNOSUPPRESSION
#23TRPC3 AS A THERAPEUTIC TARGET FOR ALZHEIMER’S DISEASE
#24CAS-READY MOUSE EMBRYONIC STEM CELLS AND MICE AND USES THEREOF
#25TELOMERASE REVERSE TRANSCRIPTASE-BASED THERAPIES
#26METHOD FOR IDENTIFYING SUBSTANCE CAPABLE OF AFFECTING AGING
#27ANTIBODY PRODUCING NON-HUMAN ANIMALS
#28Gene Expression System
#29Method of treating rheumatoid arthritis using antibodies to oxidized phospholipids
#30HUMAN LIVER CHIMERIC NON-HUMAN ANIMAL WITH DEFICIENT P450 OXIDOREDUCTASE AND METHODS OF USING SAME
#31TRANSGENIC RABBIT WITH COMMON LIGHT CHAIN
#32MULTITRANSGENIC PIGS COMPRISING TEN GENETIC MODIFICATIONS FOR XENOTRANSPLANTATION
#33NON-HUMAN ANIMAL SECRETOME MODELS
#34TRANSCRIPTION MODULATION IN ANIMALS USING CRISPR/CAS SYSTEMS
#35METHODS AND COMPOSITIONS FOR TREATMENT OF ATHEROSCLEROSIS
#36Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity in amyotrophic lateral sclerosis (ALS) by UPF2
#37TGFbeta1 Hyperactivation Causes Gender-Specific Calcific Aortic Stenosis
#38SYSTEMS AND METHODS FOR IN VIVO DUAL RECOMBINASE-MEDIATED CASSETTE EXCHANGE (dRMCE) AND DISEASE MODELS THEREOF
#39Combination Therapy for Treating Disorders of the Ear
#40NOVEL METHOD
#41METHODS FOR PRODUCING ANTIGEN-BINDING PROTEINS AGAINST FOREIGN ANTIGENS
#42GENETIC MODIFICATION OF PIGS FOR XENOTRANSPLANTATION
#43Genetically modified rat models for severe combined immunodeficiency (SCID)
#44ANIMAL MODEL FOR DRUG DEVELOPMENT
#45MODULATION OF LC3-ASSOCIATED ENDOCYTOSIS PATHWAY AND GENETICALLY MODIFIED NON-HUMAN ANIMALS AS A MODEL OF NEUROINFLAMMATION AND NEURODEGENERATION
#46Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith
#47HUMANIZED MOUSE MODEL SUSCEPTIBLE TO EMERGING CORONAVIRUSES
#48A METHOD FOR SCREENING A THERAPEUTIC AGENT FOR CANCER USING BINDING INHIBITOR OF CYCLIN-DEPENDENT KINASE 1 (CDK1)-CYCLIN B1 AND RETINOIC ACID RECEPTOR RESPONDER 1 (RARRES1) GENE KNOCKOUT ANIMAL MODEL
#49EZH2- FGFR INHIBITION IN CANCER
#50Inhibitors of alpha-tubulin acetylation for the treatment of pain
#51Genetically modified rat models for severe combined immunodeficiency (SCID)
#52Cas-ready mouse embryonic stem cells and mice and uses thereof
#53Non-human animals models of retinoschisis
#54COMPOSITIONS AND METHODS FOR REGULATING MYELINATION
#55METHODS AND COMPOSITIONS FOR ASSESSING CRISPR/CAS-MEDIATED DISRUPTION OR EXCISION AND CRISPR/CAS-INDUCED RECOMBINATION WITH AN EXOGENOUS DONOR NUCLEIC ACID IN VIVO
#56CORRECTION OF DYSTROPHIN EXON 43, EXON 45, OR EXON 52 DELETIONS IN DUCHENNE MUSCULAR DYSTROPHY
#57TELOMERASE REVERSE TRANSCRIPTASE-BASED THERAPIES
#58POLYNUCLEOTIDE
#59NON-HUMAN ANIMALS CAPABLE OF DH-DH REARRANGEMENT IN THE IMMUNOGLOBULIN HEAVY CHAIN CODING SEQUENCES
#60INDUCIBLE MODIFICATION OF A CELL GENOME
#61Transgenic mouse model of Neurofibromatosis type 1
#62Gene expression system
#63ADAM6 KNOCKIN MICE
#64GENETICALLY MODIFIED NON-HUMAN ANIMALS FOR GENERATING THERAPEUTIC ANTIBODIES AGAINST PEPTIDE-MHC COMPLEXES, METHODS OF MAKING AND USES THEREOF
#65Targeted delivery of glycine receptors to excitable cells
#66INDUCIBLE DISEASE MODELS METHODS OF MAKING THEM AND USE IN TISSUE COMPLEMENTATION
#67Mutations in rhodopsin gene in zebrafish and uses thereof
#68Reelin antibodies for treatment of atherosclerosis
#69ADIPONECTIN-EXPRESSING REGULATORY T-CELL PRECURSORS, COMPOSITION AND METHODS THEREOF
#70In vitro immune synapse system and method of in vitro evaluating immune response using the same
#71PSORIASIS-INDUCED ANIMAL MODEL AND USE THEREOF
#72CANCER IMAGING WITH THERAPY: THERANOSTICS
#73MRGPRX2/MRGPRB2 EXPRESSING CELL BASED ASSAY TO DETECT PSEUDO-ALLERGIC DRUG REACTIONS AND TO IDENTIFY BLOCKERS TO PREVENT THE ADVERSE REACTIONS
#74A GANGLIOGLIOMA-INDUCED ANIMAL MODEL AND A METHOD FOR DIAGNOSING AND TREATING GANGLIOGLIOMA AND RELATED DISEASES
#75Recombinant constructs and transgenic fluorescent ornamental fish therefrom
#76Gene-modified mouse expressing human GPC3 polypeptide
#77MICRO-RNA FAMILY THAT MODULATES FIBROSIS AND USES THEREOF
#78IN VITRO IMMUNE SYNAPSE SYSTEM AND METHOD OF IN VITRO EVALUATING IMMUNE RESPONSE USING THE SAME
#79Mouse with cholinergic neuron-specific inactivated ANO1 gene
#80Kidney production method
#81REPROGRAMMING METABOLISM BY INHIBITING VHL FOR TREATMENT OF NEURODEGENERATION
#82TRPC3 as a therapeutic target for alzheimer's disease
#83Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity by UPF1
#84Recombinant adenovirus-based interferon biotherapeutics in swine
#85MODEL SYSTEM FOR MITOCHONDRIAL DYSFUNCTION AND METHODS OF USING THE SAME
#86Recombinant AAV variants and uses thereof
#87Transgenic mice with inducible neuron-specific inactivation of HuR gene and method of screening
#88NON-HUMAN ANIMALS CAPABLE OF ENGINEERED DH-DH REARRANGEMENT AND USES THEREOF
#89Combination therapy for treating disorders of the ear
#90ANIMAL MODEL FOR DRUG DEVELOPMENT
#91Application of GPR45 gene
#92RODENT MODELS WITH AUTISTIC FEATURES
#93Urokinase-type plasminogen activator transgenic mouse
#94TRPA1 and TRPV4 inhibitors and methods of using the same for organ-specific inflammation and itch
#95Junctophilin-2 fragments and uses therefor
#96Endoplasmic reticulum-targeting nanovehicles and methods for use thereof
#97MATERIALS AND METHODS FOR MAKING A RECESSIVE GENE DOMINANT
#98GENETICALLY MODIFIED NON-HUMAN ANIMALS FOR GENERATING THERAPEUTIC ANTIBODIES AGAINST PEPTIDE-MHC COMPLEXES, METHODS OF MAKING AND USES THEREOF
#99Transcription modulation in animals using CRISPR/Cas systems
#100Methods of treating cells containing fusion genes by genomic targeting
#101PSORIASIS-INDUCED ANIMAL MODEL AND USE THEREOF
#102Recombinant bagworm silk
#103STORAGE OF PLATELETS
#104Cytoplasmic incompatibility factors and methods for controlling anthropods
#105Compositions and methods for treating and preventing metabolic disorders
#106GENE-MODIFIED NON-HUMAN ANIMAL EXPRESSING HUMAN GPC3 POLYPEPTIDE
#107Human liver chimeric mouse with deficient P450 oxidoreductase
#108Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith
#109Non-Human Animals Comprising SLC30A8 Mutation And Methods Of Use
#110Co-activation of mTOR and STAT3 pathways to promote neuronal survival and regeneration
#111ACTIVATION OF TRPV4 ION CHANNEL BY PHYSICAL STIMULI AND CRITICAL ROLE FOR TRPV4 IN ORGAN-SPECIFIC INFLAMMATION AND ITCH
#112Methods for selecting antibodies that specifically bind glycosylated immune checkpoint proteins
#113Transgenic rabbit with common light chain
#114Compositions and methods for genetically modifying myosin phosphatase target subunit (Mypt1) gene for lowering blood pressure
#115Cas-ready mouse embryonic stem cells and mice and uses thereof
#116Methods and compositions for assessing CRISPER/Cas-mediated disruption or excision and CRISPR/Cas-induced recombination with an exogenous donor nucleic acid in vivo
#117Inhibitors of α-tubulin acetylation for the treatment of pain
#118Transgenic pig which simultaneously expresses HO-1 gene and TNFR1-Fc gene, and comprises knocked-out GGTA1 gene, and use thereof
#119Human ARCAP transgenic mouse
#120Mutations in rhodopsin gene in zebrafish and uses thereof
#121Antibodies to oxidized phospholipids
#122Antibodies to oxidized phospholipids
#123Inducible modification of a cell genome
#124Genetically modified rat models for severe combined immunodeficiency (SCID)
#125Methods and compositions for treatment of atherosclerosis
#126Antibodies to oxidized phospholipids
#127Non-human animal models of retinoschisis
#128Multi-Transgenic Pig for Xenotransplantation
#129Transgenic chicken for production of antibodies having a common light chain
#130NR2E1 MINI-PROMOTERS
#131PCSK9 INHIBITORY POLYPOLYPEPTIDES AND METHODS OF USE
#132Micro-RNA family that modulates extracellular matrix genes and uses thereof
#133Transgenic Immunodeficient Mouse Expressing Human SIRP-alpha
#134SCREENING METHODS FOR TARGETS FOR CANCER THERAPY
#135Methods and compositions for translational profiling and molecular phenotyping
#136Non-obese diabetes mice and its applications
#137ANTIBODY PRODUCING NON-HUMAN ANIMALS
#138ANTIBODY PRODUCING NON-HUMAN ANIMALS
#139Antibody producing non-human animals
#140ANTIBODY PRODUCING NON-HUMAN ANIMALS
#141Antibody producing non-human animals
#142Antibody producing non-human animals
#143TRANSGENIC ANIMAL MODELS FOR CYSTIC FIBROSIS
#144Transgenic mouse model for dementia
#145Genetic modification of pigs for xenotransplantation
#146Mouse with D4R iRNA in the intercalating cell mass of the amygdala
#147Transgenic mouse capable of spatial and temporal control of expression and site-specific modification of target protein, production method and uses thereof
#148Recombinant constructs and transgenic fluorescent ornamental fish therefrom
#149Generation of an inducible pericyte-specific CRE mouse model
#150Minimally-invasive and activity-dependent control of excitable cells
#151Recombinant AAV variants and uses thereof
#152ACTIVATION OF TRPV4 ION CHANNEL BY PHYSICAL STIMULI AND CRITICAL ROLE FOR TRPV4 IN ORGAN-SPECIFIC INFLAMMATION AND ITCH
#153Optogenetic control of endothelial cells
#154ADAM12 inhibitors and their use against inflammation-induced fibrosis
#155Co-activation of mTOR and STAT3 pathways to promote neuronal survival and regeneration
#156METHODS FOR BREAKING IMMUNOLOGICAL TOLERANCE USING MULTIPLE GUIDE RNAS
#157Transgenic mammals and methods of use thereof
#158Transgenic mammals and methods of use thereof
#159TRPA1 and TRPV4 inhibitors and methods of using the same for organ-specific inflammation and itch
#160Transgenic pig models of cystic fibrosis
#161Non-human animals having an engineered ANGPTL8 gene
#162Telomerase reverse transcriptase-based therapies
#163TRANSGENIC CHICKENS WITH AN INACTIVATED ENDOGENOUS GENE LOCUS
#164MrgprX2/MrgprB2 expressing cell based assay to detect pseudo-allergic drug reactions and to identify blockers to prevent the adverse reactions
#165Red genetically encoded calcium indicators and methods of use
#166GENE EXPRESSION SYSTEM
#167ANIMAL MODEL FOR STUDYING COMPLEX HUMAN DISEASES
#168All sterile males of culicine mosquitoes: a method of creation
#169GENETICALLY MODIFIED NON-HUMAN MAMMALS HAVING MODIFIED LIVER CELLS AND/OR TISSUE AND METHODS OF MAKING SAME
#170TRANSGENIC NUCLEASE SYSTEMS AND METHODS
#171Targeted delivery of glycine receptors to excitable cells
#172Transgenic mouse for determining the role of senescent cells in cancer
#173Recombinant constructs and transgenic fluorescent ornamental fish therefrom
#174Compositions and methods for treating autoimmune and inflammatory diseases
#175Recurrent gene fusions in prostate cancer
#176STABILIZED STEP FUNCTION OPSIN PROTEINS AND METHODS OF USING THE SAME
#177Methods of identifying modulators of olfactory receptors
#178Promoter-regulated differentiation-dependent self-deleting cassette
#179Animal model and method for studying gene-gene interactions
#180Antibody production
#181Multi-transgenic pigs for diabetes treatment
#182Activation of TRPV4 ion channel by physical stimuli and critical role for TRPV4 in organ-specific inflammation and itch
#183Red genetically encoded calcium indicators and methods of use
#184CELL SPECIFIC LABELING OF NEWLY SYNTHESIZED PROTEINS
#185Transgenic non-human mammal for producing chimeric human immunoglobulin E antibodies
#186miRNA-regulated differentiation-dependent self-deleting cassette
#187Micro-RNA family that modulates fibrosis and uses thereof
#188Micro-RNA family that modulates fibrosis and uses thereof
#189Micro-RNA family that modulates fibrosis and uses thereof
#190Method for measuring cell-to-cell transmission of α-synuclein aggregates using bimolecular fluorescence complementation system and method for screening a substance for preventing or treating neurodegenerative disease using the same
#191Role of a cluster of long noncoding RNA transcripts in protecting the heart from pathological hypertrophy
#192Tilapia () myosin light chain 3 promoter
#193Use of a truncated CCN1 promoter for cancer diagnostics, therapeutics and theranostics
#194Animal Model Expressing Luciferase under Control of the Myelin Basic Protein Promoter (MBP-luci) and Use of the Model for Bioluminescence In Vivo Imaging
#195Atopic dermatitis model animal and use thereof
#196Maternally induced sterility in animals
#197Transgenic Animals With Customizable Traits
#198TGIF2-induced reprogramming of hepatic cells to pancreatic progenitor cells and medical uses thereof
#199Proteins with modified glycosylation and methods of production thereof
#200Methods of treating, preventing and diagnosing leukemia and other blood diseases and disorders
#201Reduction of TGF beta signaling in myeloid cells in the treatment of cancer
#202Fibrotic non-human animal, and use thereof
#203Regeneration of coronary artery by coronary endothelial specific progenitor cells
#204Methods of reducing TDP-43-mediated neuronal cytotoxicity in amyotrophic lateral sclerosis by a UPF1 polypeptide or polynucleotide
#205Activation of TRPV4 ion channel by physical stimuli and critical role for TRPV4 in organ-specific inflammation and itch
#206Methods for producing a population of pancreatic beta-cells
#207Optogenetic control of endothelial cells
#208Methods of treating metabolic disease
#209Biocontrol
#210Transgenic non-human vertebrate for the in vivo production of dual specificity immunoglobulins or hypermutated heavy chain only immunoglobulins
#211Urokinase-type plasminogen activator transgenic mouse
#212Methods and compositions for the treatment of insulin-associated medical conditions
#213Promoter-regulated differentiation-dependent self-deleting cassette
#214Target molecules for transcriptional control systems
#215Rodent comprising mouse artificial chromosome vector
#216Methods and compositions for translational profiling and molecular phenotyping
#217Transgenic immunodeficient mouse expressing human SIRP-alpha
#218Transgenic animal model of mood disorders
#219Model and method for a transgenic bovidae expressing cardiac fibrosis and associated pathology
#220ADAM12 inhibitors and their use against inflammation-induced fibrosis
#221Antibody producing non-human mammals
#222Antibody producing non-human mammals
#223Method and quality control molecular based mouse embryo assay for use with in vitro fertilization technology
#224Co-activation of mTOR and STAT3 pathways to promote neuronal survival and regeneration
#225Transgenic pig models of cystic fibrosis
#226Soluble protein CD5 or CD6 for the treatment of cancer or tumor or for use as an adjuvant
#227miRNA-regulated differentiation-dependent self-deleting cassette
#228Transgenic non-human animal model of neurodegenerative disease
#229Stabilized step function opsin proteins and methods of using the same
#230Transgenic mouse having a genome comprising a homozygous disruption of the endogenous MFN2 gene expression in the dopaminergic neurons
#231Antibody production
#232Promoter-regulated differentiation-dependent self-deleting cassette
#233Promoter-regulated differentiation-dependent self-deleting cassette
#234Efficient sterilization of fish by disruption of germ cell development
#235Compositions and methods relating to non-human animals modified to promote production of selected gametes
#236Transgenic animals with customizable traits
#237Micro-RNA family that modulates fibrosis and uses thereof
#238Micro-RNA family that modulates fibrosis and uses thereof
#239Preparation of recombinant human plasma phospholipid transfer protein (PLTP) from the milk of transgenic rabbits
#240Micro-RNA family that modulates fibrosis and uses thereof
#241Transgenic fish and uses thereof
#242Antibody producing non-human mammals
#243In vivo gene regulation by the combination of knock-in-tetO sequence into the genome and tetracycline-controlled trans-suppressor (tTS) protein
#244METHOD AND SYSTEM FOR MAPPING SYNAPTIC CONNECTIVITY USING LIGHT MICROSCOPY
#245IN VIVO SCREENING MODELS FOR TREATMENT OF QC-RELATED DISORDERS
#246CD4 T-cells and CD8zeta cells involved in mammalian host response to epithelial cell infections and uses thereof
#247Reduction of TGF beta signaling in myeloid cells in the treatment of cancer
#248Recurrent gene fusions in prostate cancer
#249Use of Follistatin-Like Related Gene (FLRG) to Increase Muscle Mass
#250TRANSGENIC NON-HUMAN ANIMALS
#251Maternally induced sterility in animals
#252Recurrent gene fusions in prostate cancer
#253Recurrent gene fusions in prostate cancer
#254TRANSGENIC MICE OVER-EXPRESSING RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCT (RAGE) IN BRAIN AND USES THEREOF
#255STROMAL INTERACTING MOLECULE KNOCKOUT MOUSE AND USES THEREOF
#256Mouse artificial chromosome vector
#257Female specific insect expression system
#258Isolation, Cloning, Sequencing and Functional analysis of ss-casein promoter along with the regions of exon1, intron1 and exon2 using mammary gland derived cell line of Buffalo (Bubulus bubalis)
#259METHODS AND SYSTEMS FOR INDUCIBLE ABLATION OF NEURAL CELLS
#260MO-1 conditional knock-out non-human animal and uses thereof
#261ADAM12 Inhibitors and Their Use Against Inflammation-Induced Fibrosis
#262Transgenic mouse conditionally expressing MMP12 for studying myelopoiesis, immunity and tumorigenesis
#263UBIQUITIN INTERACTING MOTIF PEPTIDES AS CANCER THERAPEUTICS
#264Genetically modified rat models for severe combined immunodeficiency (SCID)
#265Compositions and methods relating to non-human animals modified to promote production of selected gametes
#266F1B-TMIR plasmid vector and transgenic mouse
#267Targeted and regional cellular ablation in zebrafish
#268Method for preventing and treating cardiovascular diseases with BRCA1
#269Site-directed integration of transgenes in mammals
#270IN VIVO SCREENING MODELS FOR TREATMENT OF isoQC-RELATED DISORDERS
#271Caveolin 1-reporter protein knock-in mouse
#272Methods for Conditional and Inducible Transgene Expression to Direct the Development of Embryonic, Embryonic Stem, Precursor and Induced Pluripotent Stem Cells
#273NOVEL USES OF VEGFXXXB
#274Non-human animal model for amyotrophic lateral sclerosis (ALS) with loss-of-TDP-43 function
#275Non human transgenic mammal comprising a transgene comprising a nucleotide sequence encoding a ribosomal protein fused to a peptide tag
#276ANTIBODY PRODUCTION
#277ASSAY FOR SCREENING ANTIDEPRESSANTS
#278Animal Model for Osteoarthritis and Intervertebral Disc Disease
#279NUCLEAR RECEPTOR SENSOR SYSTEM IN TRANSGENIC ANIMAL
#280THERAPEUTIC AGENT FOR MLL LEUKEMIA AND MOZ LEUKEMIA OF WHICH MOLECULAR TARGET IS M-CSF RECEPTOR, AND USE THEREOF
#281INHIBITING OBESITY PROGRESSION BY INHIBITING ADIPOCYTE DIFFERENTIATION WITH A PRE-ADIPOCYTE AUTOPHAGY INHIBITOR
#282Gene of porcine alpha-s1 casein, a promoter of the same and use thereof
#283Transgenic fish and uses thereof
#284Potential Prognostic Markers and Therapeutic Targets for Neurological Disorders
#285Female specific insect expression system
#286Targeted delivery of glycine receptors to excitable cells
#287METHOD OF TREATMENT USING ANTIMICROBIAL COMPOSITION
#288Enterovirus type 71 protein and method for production
#289MODULATION OF GM98 (MRF) IN REMYELINATION
#290Targeting TGF-β as a therapy for Alzheimer's disease
#291MK167 mini-promoters
#292Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) in brain and uses thereof
#293Efficient Insertion of DNA Into Embryonic Stem Cells
#294CLDN5 mini-promoters
#295DEVELOPMENT STAGE-SPECIFIC LETHALITY SYSTEM FOR INSECT POPULATION CONTROL
#296METHODS AND COMPOSITIONS FOR TRANSLATIONAL PROFILING AND MOLECULAR PHENOTYPING
#297Animal Model of Synovial Sarcoma
#298METHODS FOR CLONING FERRETS AND TRANSGENIC FERRET MODELS FOR DISEASES
#299Promoter-regulated differentiation-dependent self-deleting cassette
#300miRNA-regulated differentiation-dependent self-deleting cassette